Avidity Biosciences, Inc.
General ticker "RNA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.9B (TTM average)
Avidity Biosciences, Inc. follows the US Stock Market performance with the rate: 38.7%.
Estimated limits based on current volatility of 3.0%: low 13.65$, high 14.48$
Factors to consider:
- Total employees count: 391 (+54.5%) as of 2024
- Top business risk factors: Need for additional capital, Limited operating history, Clinical trial success, Regulatory and compliance, Market competition
Short-term RNA quotes
Long-term RNA plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $18.62MM |
| Operating Expenses | $95.43MM |
| Operating Income | $-76.81MM |
| Non-Operating Income | $-0.01MM |
| R&D Expense | $53.76MM |
| Income(Loss) | $-76.83MM |
| Taxes | $-0.14MM |
| Profit(Loss)* | $-103.87MM |
| Stockholders Equity | $207.29MM |
| Assets | $278.35MM |
| Operating Cash Flow | $-41.13MM |
| Capital expenditure | $1.45MM |
| Investing Cash Flow | $-1.45MM |
| Financing Cash Flow | $42.57MM |
| Earnings Per Share** | $-6.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.